Teva's FDA Testing Violates Lovenox Patent, Fed. Circ. Told
Momenta Pharmaceuticals Inc. urged the Federal Circuit to revive patent suits against Teva Pharmaceutical Industries Ltd. and Amphastar Pharmaceuticals Inc., saying Monday that the generics makers use U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article